DK102857C - Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener. - Google Patents
Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener.Info
- Publication number
- DK102857C DK102857C DK232161AA DK232161A DK102857C DK 102857 C DK102857 C DK 102857C DK 232161A A DK232161A A DK 232161AA DK 232161 A DK232161 A DK 232161A DK 102857 C DK102857 C DK 102857C
- Authority
- DK
- Denmark
- Prior art keywords
- pregnadienes
- keto
- trifluoromethyl
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2019060 | 1960-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK102857C true DK102857C (da) | 1965-10-18 |
Family
ID=10141901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK232161AA DK102857C (da) | 1960-06-08 | 1961-06-08 | Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener. |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH401960A (da) |
| DK (1) | DK102857C (da) |
| ES (1) | ES268064A1 (da) |
-
1961
- 1961-06-08 DK DK232161AA patent/DK102857C/da active
- 1961-06-08 ES ES0268064A patent/ES268064A1/es not_active Expired
- 1961-06-08 CH CH668161A patent/CH401960A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES268064A1 (es) | 1961-11-16 |
| CH401960A (de) | 1965-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK113988B (da) | Fremgangsmåde til fremstilling af 1,6-dibrom-1,6-didesoxy-D-mannitol. | |
| DK112306B (da) | Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater. | |
| DK104302C (da) | Fremgangsmåde til fremstilling af 4-fluor-3,20-diketo-Δ<4>-21-brompregnener. | |
| DK101297C (da) | Fremgangsmåde til fremstilling af 3-keto-6α-trifluormethyl-Δ<1,4>-pregnadiener. | |
| DK98239C (da) | Fremgangsmåde til fremstilling af 2-alkoxy-3,17-diketo-11β-hydroxy-Δ<1,4>-androstadiener. | |
| DK97513C (da) | Fremgangsmåde til fremstilling af 3,11-dioxo-17α-hydroxy-20β,21-dinitrato-Δ<4>-pregnen. | |
| DK101056C (da) | Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<1,4,6>-pregnatriener. | |
| DK96739C (da) | Fremgangsmåde til fremstilling af 3-keto-17β-hydroxy-17α-ethynyl-Δ<5(10),9(11)>-estradien. | |
| DK100230C (da) | Fremgangsmåde til fremstilling af 3-amino-17β-acyloxy-Δ<1,3,5(10),9(11)>-estratetraener. | |
| DK100614C (da) | Fremgangsmåde til fremstilling af 3-amino-17β-acyloxy-Δ<1,3,5(10)9(11)>-estratetraener. | |
| DK100166C (da) | Fremgangsmåde til fremstilling af 3,20-diketo-17α-hydroxy-21-acetoxy-16α-methyl-Δ<4,9(11)>-pregnadien. | |
| DK96053C (da) | Fremgangsmåde til fremstilling af Δ<1,4>-3-ketosteroider. | |
| DK97823C (da) | Fremgangsmåde til fremstilling af 3-alkoksy-Δ<3,5>-pregnadienforbindelser. | |
| DK99567C (da) | Fremgangsmåde til fremstilling af 4-oxa-tetracyclo-(6:2:1:0<2,7>:0<3,5>)-hendecanderivater. | |
| DK94561C (da) | Fremgangsmåde til fremstilling af 3-acyloxy-2,4,6-pregnatrienforbindelser. | |
| DK98001C (da) | Fremgangsmåde til fremstilling af 3-oxo-14-hydroxy-11α,19-diacetoxy-(1,4)-cardadienolid. | |
| DK97819C (da) | Fremgangsmåde til fremstilling af 1-metyl-17α-alkyl- eller 17α-vinyl-Δ<1>-androsten-17β-ol-3-oner. | |
| DK98177C (da) | Fremgangsmåde til fremstilling af 11β,18-oxido-methyl-3,20-diketo-δ<4>-pregnen. | |
| DK108858C (da) | Fremgangsmåde til fremstilling af 19-hydroxy- eller 19-acyloxy-Δ<4,6>-3-oxo-steroider. | |
| DK98496C (da) | Fremgangsmåde til fremstilling af 6-halogen-1,2α-metylen-Δ<6>-17α-acyloksyprogesteroner. | |
| DK104404C (da) | Fremgangsmåde til fremstilling af 10-alkenyl-δ<1,4>-3-keto-steroider. | |
| DK97939C (da) | Fremgangsmåde til fremstilling af 3,11,20-trioxo-18-nor-Δ<4>-pregnen. | |
| DK112870B (da) | Fremgangsmåde til fremstilling af 17α-metyl-Δ<1,4>-androstadien-17β-ol-3-on. | |
| DK98959C (da) | Fremgangsmåde til fremstilling af derivater af 5,6-dihydropyridoner. | |
| DK103076C (da) | Fremgangsmåde til fremstilling af derivater af 5,6-dihydro-pyridoner. |